An inactivated avian polyomavirus vaccine is safe and immunogenic in various Psittaciformes.
The safety and immunogenicity of adjuvanted and nonadjuvanted inactivated avian polyomavirus vaccines, administered either intramuscularly or subcutaneously (s.c.), were evaluated in a group of mixed species Psittaciformes. In 233 vaccinates representing species of macaws, cockatoos, conures, and parrots, gross reactions were limited to small scab formation at the s.c. injection site in three African grey parrots. Both vaccines stimulated a virus neutralizing (VN) antibody response, particularly in birds that were seronegative prior to vaccination. Ninety-three percent of the birds that were seronegative at the beginning of the study seroconverted (greater than fourfold increase in VN antibody titer) by 2 weeks after the second vaccination. Seventy-six percent of all the vaccinates had at least a fourfold increase in VN antibody titer at this time. There was no significant difference in seroconversion between the birds vaccinated with adjuvanted or nonadjuvanted vaccines. This study indicates that an inactivated avian polyomavirus vaccine can be used to safely immunize various species of psittacine birds in a field setting.
Department of Small Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens 30602, USA.
B W
BW
Ritchie
F D
FD
Niagro
K S
KS
Latimer
N
N
Pritchard
R P
RP
Campagnoli
P D
PD
Lukert
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D001717:Birds; D009500:Neutralization Tests; D011120:Polyomavirus / Q000276:immunology*; D015164:Vaccines, Inactivated / Q000009:adverse effects* / Q000276:immunology*; D014765:Viral Vaccines / Q000009:adverse effects* / Q000276:immunology*
D000914:Antibodies, Viral; D015164:Vaccines, Inactivated; D014765:Viral Vaccines